Company Overview
About BIOS Health
BIOS Health is a neural interface and closed-loop neuromodulation company developing bioelectronic medicine devices for treating chronic conditions. Founded in 2017 as a spinout from Cambridge University, BIOS Health builds implantable devices and software platforms that decode peripheral nerve signals to restore physiological function in patients with conditions including diabetes, hypertension, and inflammatory diseases. The company's approach combines machine learning with neural signal processing to enable real-time, adaptive therapy.
Business Model & Competitive Advantage
The company raised $45 million in Series B funding in 2022, led by Khosla Ventures and joined by GlaxoSmithKline's bioelectronic medicine unit. BIOS Health has partnered with major pharmaceutical companies and academic medical centers to validate its neural decoding technology in clinical settings. By 2024, the company had advanced several device programs toward clinical trials, targeting conditions where bioelectronic stimulation can modulate organ function without systemic drug side effects.
Competitive Landscape 2025–2026
In 2025, BIOS Health operates at the frontier of neuromodulation, competing with established players like Abbott and Medtronic as well as newer entrants like Galvani Bioelectronics. The company's distinctive edge is its software-defined approach — the same hardware platform can be reprogrammed for different indications, reducing development costs and enabling rapid iteration based on clinical feedback. BIOS Health's 2025-2026 pipeline focuses on autonomic nervous system applications with significant unmet need.
Open Positions
Reddit Discussions
Key Differentiators
Emerging Innovator
BIOS Health is an emerging player bringing innovative solutions to the Healthcare market.
Frequently Asked Questions
Not So Random Others
AbbVie
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Sp
Yoneda Labs
Yoneda Labs is a San Francisco-based AI company applying foundation models to automate chemical reaction optimization for drug discovery and pharmaceutical process development — providing chemists wit
YouShift
YouShift is a United States-based AI healthcare workforce management platform — building the operating system for healthcare staffing starting with AI-powered scheduling agents that replace the comple
Decoda Health
Decoda Health is a San Francisco-based AI healthcare administration platform — backed by Y Combinator (S23) with $4.5 million raised from YC, Amino Capital, Bossa Nova Ventures, Cadenza Ventures, Grap
Uncommon Therapeutics
Uncommon Therapeutics is a biotech company founded by Noah Auerhahn — directly inspired by his daughter's diagnosis with Rett Syndrome, a severe genetic neurological disease affecting approximately 1
Fortuna Health
Fortuna Health is a New York City-based healthcare technology company — backed by Y Combinator with $22 million in total funding including an $18 million Series A in July 2025 led by Andreessen Horowi
Compare BIOS Health with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from BIOS Health? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim BIOS Health Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention BIOS Health vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →